Pharma Giant To Make Largest-Ever Investment In United States

Pharmaceutical industry company AstraZeneca plans to invest $4.5 billion on two manufacturing facilities in Virginia.

The project, which is the British-Swedish corporation’s largest-ever investment, is projected to create about 600 jobs.

The investment is estimated to create about 3,000 additional indirect jobs.

“Today we announced our plans to invest $4.5 billion in a new manufacturing facility in Virginia. This includes a proposed $500m increase to support enhanced manufacturing capability, driving life sciences innovation and economic growth,” the company stated.

#News Today we announced our plans to invest $4.5 billion in a new manufacturing facility in Virginia. This includes a proposed $500m increase to support enhanced manufacturing capability, driving life sciences innovation and economic growth: https://t.co/7INh1kgDZA pic.twitter.com/2dvIDKMSlb

— AstraZenecaUS (@AstraZenecaUS) October 9, 2025

“With our $4.5 billion investment in Virginia, we are not only building a state-of-the-art manufacturing facility, but also driving life sciences innovation and economic growth,” AstraZeneca Chief Executive Officer Pascal Soriot said, according to Virginia Mercury.

“This new facility will create thousands of jobs and strengthen America’s national security and health sovereignty. We have found in Virginia an amazing team that moves at incredible speed to build a better future for this commonwealth and the American people,” Soriot added.

“This investment will create 600 new high-paying jobs that focus on chronic disease care and prevention, which makes a positive impact both economically and in Americans health. Albemarle is the perfect location for these facilities, and this investment will ensure secure, long-term growth for the Commonwealth’s economy,” Rep. John McGuire (R-VA) said.

“As your Congressman, my team and I have been working with various companies to bring jobs, manufacturing, and economic development to Virginia’s Fifth District. I want to thank President Trump, @GovernorVA, @DrOzCMS, @juanpablo4VA, Albemarle County, and AstraZeneca for making this investment a reality,” he added.

WIN FOR VA-05! I was proud to participate and speak in AstraZeneca’s economic development announcement of $4.5 billion investment to establish two new manufacturing facilities in Albemarle County.

This investment will create 600 new high-paying jobs that focus on chronic… pic.twitter.com/I4Pr03PlOO

— Congressman John McGuire (@RepJohnMcGuire) October 9, 2025

More from Virginia Mercury:

Youngkin credited the Virginia Talent Accelerator Program and the Virginia Business Ready Sites Program for helping the state secure the deal. The Virginia Economic Development Partnership worked alongside Albemarle County and the General Assembly’s Major Employment and Investment Project Approval Commission to bring the project to fruition.

To support the investment, AstraZeneca will be eligible for a special appropriation of up to $191.3 million, contingent on state legislative approval, tied to the creation of 500 jobs at its chronic disease facility. A second grant from the commonwealth’s Opportunity Fund will support the cancer-therapy facility.

Secretary of Commerce and Trade Juan Pablo Segura said the deal highlights Virginia’s competitive advantages in biotech and advanced manufacturing.

ADVERTISEMENT

“AstraZeneca has never shied away from the hardest challenges: cancer, obesity, heart disease, and more,” Segura said. “Their $4.5 billion investment in Virginia is a powerful vote of confidence in what our Commonwealth has to offer.”

Local officials hailed the project as a big win for Albemarle County.

“AstraZeneca brings transformative investment to Albemarle County, creating high-quality jobs with competitive wages for our local workforce,” Board of Supervisors Chair Jim Andrews said.

“AstraZeneca’s $4.5 billion investment is the largest single manufacturing investment in the company’s history and a game-changer for American drug manufacturing,” Virginia Gov. Glenn Youngkin said.

“The investment is set to create 600 high-paying jobs in Albemarle County, strengthening America’s ability to produce lifesaving medicines right here in Virginia. It took just 33 days from our first conversation to partnering on this project – that’s moving at Virginia speed. Thanks to programs like the Virginia Business Ready Sites Program and the Virginia Talent Accelerator Program, AstraZeneca will be able to hit the ground running. There is a true business renaissance happening in Virginia, and I want to thank Pascal and the entire AstraZeneca team for choosing to invest in Virginia and for trusting the Commonwealth as a partner in the future of a world-class company,” he added.

Reuters noted:

The company also said it was expanding plans for the site to include production of blockbuster cancer medicines along with future weight-loss and metabolic drugs. It said it would spend $500 million more than initially planned.

The groundbreaking was attended by a senior Trump administration health official, Dr Mehmet Oz, Administrator of the Centers for Medicare and Medicaid Services.

ADVERTISEMENT

“I congratulate AstraZeneca for their investment and invite other foreign manufacturers to follow suit,” he said.

Trump has, using the threat of imposing tariffs on pharmaceutical imports, extracted a range of concessions from the industry.